COVID-19 testing service now available from MDNA's UK laboratory: Click here ›

MDNA Life Sciences Appoints Orion Diagnostica as Exclusive Distributor in Key European Markets for the Mitomic® Prostate Test

MDNA Life Sciences Inc. (MDNA), the molecular diagnostics company revolutionizing the development of liquid biopsy biomarkers based on the mitochondrial genome, announced today that it has appointed Orion Diagnostica Oy (Orion) as the exclusive distributor for the Mitomic® Prostate Test (MPT™) in Germany, Denmark, Finland, Sweden, Norway, Poland, Czech Republic, Slovakia, and Hungary.